162 related articles for article (PubMed ID: 38542291)
41. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
42. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
43. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
Gong W; Tian M; Qiu H; Yang Z
Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
[TBL] [Abstract][Full Text] [Related]
44. An age stratified analysis of the biomarkers in patients with colorectal cancer.
Yao H; Li C; Tan X
Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836
[TBL] [Abstract][Full Text] [Related]
45. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
46. RNA processing genes characterize RNA splicing and further stratify colorectal cancer.
Lu X; Zhou Y; Meng J; Jiang L; Gao J; Cheng Y; Yan H; Wang Y; Zhang B; Li X; Yan F
Cell Prolif; 2020 Aug; 53(8):e12861. PubMed ID: 32596958
[TBL] [Abstract][Full Text] [Related]
47. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
48. MicroRNAs as biomarkers in colorectal cancer.
Schee K; Fodstad Ø; Flatmark K
Am J Pathol; 2010 Oct; 177(4):1592-9. PubMed ID: 20829435
[TBL] [Abstract][Full Text] [Related]
49. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer.
Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T
Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956
[TBL] [Abstract][Full Text] [Related]
50. Expression Characteristics and Clinical Correlations of BRD1 in Colorectal Cancer Samples.
Li Z; Wang J; Ji Y; Song F
Technol Cancer Res Treat; 2021; 20():15330338211039678. PubMed ID: 34482774
[TBL] [Abstract][Full Text] [Related]
51. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
52. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
53. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
54. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
55. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
56. Construction of a Colorectal Cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
[TBL] [Abstract][Full Text] [Related]
57. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
58. Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization.
Peixoto C; Lopes MB; Martins M; Casimiro S; Sobral D; Grosso AR; Abreu C; Macedo D; Costa AL; Pais H; Alvim C; Mansinho A; Filipe P; Costa PMD; Fernandes A; Borralho P; Ferreira C; Malaquias J; Quintela A; Kaplan S; Golkaram M; Salmans M; Khan N; Vijayaraghavan R; Zhang S; Pawlowski T; Godsey J; So A; Liu L; Costa L; Vinga S
BMC Bioinformatics; 2023 Jan; 24(1):17. PubMed ID: 36647008
[TBL] [Abstract][Full Text] [Related]
59. lncRNAs AC156455.1 and AC104532.2 as Biomarkers for Diagnosis and Prognosis in Colorectal Cancer.
Kuang F; Luo D; Zhou M; Du J; Yang J
Dis Markers; 2022; 2022():4872001. PubMed ID: 36277972
[TBL] [Abstract][Full Text] [Related]
60. Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance.
Li Z; Chen J; Zhu D; Wang X; Chen J; Zhang Y; Lian Q; Gu B
BMC Genom Data; 2022 Jul; 23(1):51. PubMed ID: 35794546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
